Request Sample Inquiry
3D Cell Culture Market

3D Cell Culture Market

3D Cell Culture Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

163

Base Year:

2021

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1286

Segments Covered
  • By Technology Scaffold Based, Scaffold Free, 3D Bioreactors
  • By Application Cancer, Tissue Engineering & Immunohistochemistry, Drug Development, Stem Cell Research, Others
  • By End Use Biotechnology and Pharmaceutical Industries, Research Laboratories and Institutes, Hospitals and Diagnostic Centers, Others
  • By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: USD 905.8 Million
Revenue 2028Revenue 2028: USD 2,051.5 Million
Revenue CAGRRevenue CAGR (2022 - 2028): 15.1%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
3D Cell Culture Market Share

Market Synopsis:

The Global 3D Cell Culture Market was valued at USD 905.8 Million in the year 2021 and is expected to reach a value of USD 2,051.5 Million by the year 2028. The Global Market is anticipated to grow to exhibit a Compound Annual Growth Rate (CAGR) of 15.1% over the forecast period.

3D Cell Culture Market Size, 2021 To 2028 (USD Million)

3D Cell Culture are commonly utilized in research that requires in vivo model systems to assess the effects of a foreign substance on bodily tissues and organs since they can precisely resemble the morphology and microarchitecture of organs. In addition, using biomimetic tissue constructs to build 3D organotypic structures prompted many research organizations to embrace 3-dimensional cell culture techniques. Furthermore, using 3D tissue-engineered models for Covid-19, cancer, and other clinical illnesses has emerged as a viable alternative to traditional methods. Compared to 2D approaches, this has a lot of promise in delivering a reasonably simple and inexpensive in vitro tumor-host environment.

The pandemic of COVID-19 is predicted to influence the market significantly. Therefore, researchers working on COVID-19 must explore in vitro the processes of systemic repercussions of cell cultures and test future therapeutics in a physiological milieu using appropriate matrices for 3D Cell Culture and suitable for air-liquid interface culture. The utilization of 3D Cell Culture in COVID-19 research is primarily for this reason.

Cancer genomics is one of the essential applications of the 3D Cell Culture Market. According to GLOBOCAN, cancer cases would increase to almost 30 million by 2040, up from 19.3 million cases and ten million cancer deaths in 2020. Because of the rising frequency of this disease, more study is needed for diagnosis and treatment; 3D Cell Culture is an essential aspect of this research. Individual cell analysis allows for accurate illness diagnosis and therapy efficacy monitoring. In breast cancer and other malignancies, 3D Cell Culture aids in identifying helper T-cells, detecting DNA content, and monitoring tumor cell proliferation.

Because of the requirement to maintain high-quality standards (the use of high-grade, expensive items) and adhere to regulatory rules, cell biology research has a high cost. However, due to funding constraints, research and academic laboratories cannot purchase such expensive instruments. In addition, these instruments' total cost of ownership rises due to maintenance charges and additional indirect expenses. This is a key stumbling block to the widespread use of flow cytometers and microfluidic devices in clinical and research settings.

Market Segmentation:

The Global 3D Cell Culture Market is segmented on the basis of Technology into Scaffold based, Scaffold free, and 3D Bioreactors. Based on Application, the market is divided into Cancer, Tissue engineering & Immunohistochemistry, Drug development, Stem cell research, and others. By End-Use, the market is fragmented into Biotechnology & pharmaceutical industries, Research laboratories & institutes, Hospitals & diagnostic centers, and others. Finally, based on region, the 3D Cell Culture Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Below tree is interactive. You can click the nodes to get more information.

North America to Continue Dominating the 3D Cell Culture Market

In 2021, North America dominated the 3D Cell Culture Market over the forecast period. Because of the availability of private and government funding for the development of advanced 3D cell culture models, high healthcare spending, and a large number of universities and research organizations investigating various stem cell-based approaches, the region will maintain its leadership position throughout the forecast period. For example, researchers from the Mayo Clinic and the Terasaki Institute in the United States discovered transparent hydrogels that can be used to monitor and manage hemorrhages in December 2020.

Competitive Landscape:

The key players in the Global 3D Cell Culture Market include- Thermo Fisher Scientific (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza Group AG (Switzerland), Avantor Inc. (US), Tecan Trading AG (Switzerland), 3D Biotek LLC (US), REPROCELL Inc. (Japan), Kirkstall Ltd (UK), MIMETAS BV (Netherlands), PromoCell GmbH (Germany), Emulate Inc. (US), CN Bio Innovations (UK), InSphero AG (Switzerland), Greiner Bio-One International GmbH (Austria), TissUse GmbH (Germany), and others.

Segmentation of the Global 3D Cell Culture Market:

Parameter Details
Segments Covered
  • Technology (Scaffold Based, Scaffold Free, 3D Bioreactors)
  • Application (Cancer, Tissue Engineering & Immunohistochemistry, Drug Development, Stem Cell Research, Others)
  • End Use (Biotechnology and Pharmaceutical Industries, Research Laboratories and Institutes, Hospitals and Diagnostic Centers, Others)
  • Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Thermo Fisher Scientific (US)
  • Merck KGaA (Germany)
  • Corning Incorporated (US)
  • Lonza Group AG (Switzerland)
  • Avantor Inc. (US)
  • Tecan Trading AG (Switzerland)
  • 3D Biotek LLC (US)
  • REPROCELL Inc. (Japan)
  • Kirkstall Ltd (UK)
  • MIMETAS BV (Netherlands)
  • PromoCell GmbH (Germany)
  • Emulate Inc. (US)
  • CN Bio Innovations (UK)
  • InSphero AG (Switzerland)
  • Greiner Bio-One International GmbH (Austria)
  • TissUse GmbH (Germany)
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

3D Cell Culture Market Projected to Reach Valuation of USD 2,051.5 Million by 2028
In terms of revenue, the Global 3D Cell Culture Market is expected to reach USD 2,051.5 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 15.1% from 2022 to 2028. Increasing focus on personalized medicine, rising awareness on developing alternatives to animal testing, large funding...
FAQ
Frequently Asked Question
  • The global 3D Cell Culture valued at USD 905.8 Million in 2020 and is expected to reach USD 2,051.5 Million in 2028 growing at a CAGR of 15.1%.

  • The prominent players in the market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza Group AG (Switzerland), Avantor Inc. (US), Tecan Trading AG (Switzerland), 3D Biotek LLC (US), REPROCELL Inc. (Japan), Kirkstall Ltd (UK), MIMETAS BV (Netherlands), PromoCell GmbH (Germany), Emulate Inc. (US), CN Bio Innovations (UK), InSphero AG (Switzerland), Greiner Bio-One International GmbH (Austria), TissUse GmbH (Germany).

  • The market is project to grow at a CAGR of 15.1% between 2021 and 2028.

  • The driving factors of the 3D Cell Culture include

    • Growing Prevalence of Cancer

  • North America was the leading regional segment of the 3D Cell Culture in 2020.